BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 24025329)

  • 1. Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID).
    Watashi K; Liang G; Iwamoto M; Marusawa H; Uchida N; Daito T; Kitamura K; Muramatsu M; Ohashi H; Kiyohara T; Suzuki R; Li J; Tong S; Tanaka Y; Murata K; Aizaki H; Wakita T
    J Biol Chem; 2013 Nov; 288(44):31715-27. PubMed ID: 24025329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
    He X; Li J; Wu J; Zhang M; Gao P
    Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of TNF-α-AID axis and co-inhibitory signals in coordination with Th1-type immunity in a mouse model recapitulating hepatitis B.
    Matsumoto T; Takahashi K; Inuzuka T; Kim SK; Kurosaki T; Kawakami S; Chiba T; Seno H; Marusawa H
    Antiviral Res; 2017 Mar; 139():138-145. PubMed ID: 28063995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.
    Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter.
    Ibrahim MK; Abdelhafez TH; Takeuchi JS; Wakae K; Sugiyama M; Tsuge M; Ito M; Watashi K; El Kassas M; Kato T; Murayama A; Suzuki T; Chayama K; Shimotohno K; Muramatsu M; Aly HH; Wakita T
    J Virol; 2021 Jul; 95(15):e0076721. PubMed ID: 33980595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
    Vartanian JP; Henry M; Marchio A; Suspène R; Aynaud MM; Guétard D; Cervantes-Gonzalez M; Battiston C; Mazzaferro V; Pineau P; Dejean A; Wain-Hobson S
    PLoS Pathog; 2010 May; 6(5):e1000928. PubMed ID: 20523896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA.
    Kitamura K; Wang Z; Chowdhury S; Simadu M; Koura M; Muramatsu M
    PLoS Pathog; 2013; 9(5):e1003361. PubMed ID: 23696735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
    J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
    Nair S; Zlotnick A
    J Virol; 2018 May; 92(10):. PubMed ID: 29491156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling.
    Endo Y; Marusawa H; Kinoshita K; Morisawa T; Sakurai T; Okazaki IM; Watashi K; Shimotohno K; Honjo T; Chiba T
    Oncogene; 2007 Aug; 26(38):5587-95. PubMed ID: 17404578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection.
    Hösel M; Quasdorff M; Wiegmann K; Webb D; Zedler U; Broxtermann M; Tedjokusumo R; Esser K; Arzberger S; Kirschning CJ; Langenkamp A; Falk C; Büning H; Rose-John S; Protzer U
    Hepatology; 2009 Dec; 50(6):1773-82. PubMed ID: 19937696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
    Xia Y; Stadler D; Lucifora J; Reisinger F; Webb D; Hösel M; Michler T; Wisskirchen K; Cheng X; Zhang K; Chou WM; Wettengel JM; Malo A; Bohne F; Hoffmann D; Eyer F; Thimme R; Falk CS; Thasler WE; Heikenwalder M; Protzer U
    Gastroenterology; 2016 Jan; 150(1):194-205. PubMed ID: 26416327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Virus Particles Activate Toll-Like Receptor 2 Signaling Initially Upon Infection of Primary Human Hepatocytes.
    Zhang Z; Trippler M; Real CI; Werner M; Luo X; Schefczyk S; Kemper T; Anastasiou OE; Ladiges Y; Treckmann J; Paul A; Baba HA; Allweiss L; Dandri M; Gerken G; Wedemeyer H; Schlaak JF; Lu M; Broering R
    Hepatology; 2020 Sep; 72(3):829-844. PubMed ID: 31925967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase.
    Liang G; Kitamura K; Wang Z; Liu G; Chowdhury S; Fu W; Koura M; Wakae K; Honjo T; Muramatsu M
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2246-51. PubMed ID: 23341589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
    Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative effects of hepatitis B virus and TNF may play important roles in the activation of metabolic pathways through the activation of NF-κB.
    Wu S; Kanda T; Nakamoto S; Jiang X; Nakamura M; Sasaki R; Haga Y; Shirasawa H; Yokosuka O
    Int J Mol Med; 2016 Aug; 38(2):475-81. PubMed ID: 27315566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β triggers HBV cccDNA degradation through AID-dependent deamination.
    Qiao Y; Han X; Guan G; Wu N; Sun J; Pak V; Liang G
    FEBS Lett; 2016 Feb; 590(3):419-27. PubMed ID: 26867650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response.
    Stoop JN; Woltman AM; Biesta PJ; Kusters JG; Kuipers EJ; Janssen HL; van der Molen RG
    Hepatology; 2007 Sep; 46(3):699-705. PubMed ID: 17654744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effect of APOBEC3G on Hepatitis B virus.
    Noguchi C; Hiraga N; Mori N; Tsuge M; Imamura M; Takahashi S; Fujimoto Y; Ochi H; Abe H; Maekawa T; Yatsuji H; Shirakawa K; Takaori-Kondo A; Chayama K
    J Gen Virol; 2007 Feb; 88(Pt 2):432-440. PubMed ID: 17251560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
    Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.